Search

Your search keyword '"Hegazy MI"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Hegazy MI" Remove constraint Author: "Hegazy MI"
33 results on '"Hegazy MI"'

Search Results

1. Sensitivity and Specificity of Central Vein Sign as a Diagnostic Biomarker in Egyptian Patients with Multiple Sclerosis

2. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

3. Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

4. Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization

5. Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients

6. Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study

7. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

8. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000-2018

9. Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study

10. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016

11. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

12. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016

13. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

14. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

15. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

16. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

17. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

18. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017

19. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

20. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

21. New algorithmic approach for easier and faster extended disability status scale calculation.

22. ٍSome biologically active microorganisms have the potential to suppress mosquito larvae ( Culex pipiens , Diptera: Culicidae).

23. Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study.

24. Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study.

25. Rainwater-driven microbial fuel cells for power generation in remote areas.

26. The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt.

27. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.

28. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.

29. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

30. Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients.

31. Prediction of Functional Outcome in Ischemic Stroke Patients: An Observational Study on Egyptian Population.

32. Evaluation of local varieties of Egyptian rice.

Catalog

Books, media, physical & digital resources